The IDEA Project's 2024 surveillance initiative focuses on collecting clinical data on fragrance allergies to assess the effectiveness of preventive measures. Launched in response to concerns from the SCCS, this effort collaborates with 10 clinics across eight European countries, ensuring high-quality patch test readings. Testing began in November 2024, with initial patient data expected by year-end. In 2025, the first testing round will be completed, with outcomes analyzed to refine methodologies and enhance the study's reliability.
Find out more about the IDEA project by visiting: https://ideaproject.info/
